Pathways to Biomedical Discovery

Philosophy of Science

Volumn 70, Issue 2, 2003, Pages 235-254

  Thagard, Paul ^a  

^a UNIVERSITY OF WATERLOO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 1542498607     PISSN: 00318248     EISSN: None     Source Type: Journal    
DOI: 10.1086/375465     Document Type: Article

References (46)

1. Achtman, Mark, Sebastian Suerbaum (eds.) (2001), Helicobacter pylori: Molecular and Cellular Biology. Oxford: Horizon Scientific Press.
2. Allen, Colin, Marc Bekoff, and George Lauder (eds.) (1998), Nature's Purposes. Cambridge, MA: MIT Press.
3. Bechtel, William, and Robert C. Richardson (1993), Discovering Complexity. Princeton: Princeton University Press.
4. Biocarta (2002), "Charting Pathways of Life", http://www.biocarta.com/genes/index.asp.
5. Boorse, Christopher (1977), "Health as a Theoretical Concept", Philosophy of Science 44: 542-573.
6. Caplan, Arthur L. (1992), "If Gene Therapy Is the Cure, What Is the Disease?", in George J. Annas and Sherman Elias (eds.), Gene Mapping: Using Law and Ethics as Guides. Oxford: Oxford University Press.
7. Caplan, Arthur L.,H. Tristram Engelhardt, and James M. McCartney (eds.) (1981), Concepts of Health and Disease: Interdisciplinary Perspectives. Reading, MA: Addison-Wesley.
8. Carpenter, William T., and Robert W. Buchanan (1994), "Schizophrenia", New England Journal of Medicine 330: 681-690.
9. Chesselet, Marie-Françoise, and Jill M. Delfs (1996), "Basal Ganglia and Movement Disorders: An Update", Trends in Neurosciences 19: 417-422.
10. Craver, Carl F. (2001), "Role Functions, Mechanisms, and Hierarchy", Philosophy of Science 68: 53-74.
11. Darden, Lindley (2002), "Strategies for Discovering Mechanisms: Schema Instantiation, Modular Subassembly, Forward/Backward Chaining", Philosophy of Science 69 (Proceedings): S354-S365.
12. Darden, Lindley, and Joseph Cain (1989), "Selection Type Theories", Philosophy of Science 56: 106-129.
13. Endo, Akira (1992), "The Discovery and Development of Hmg-Coa Reductase Inhibitors", Journal of Lipid Research 33: 1569-1582.
14. Engelhardt, H. Tristram (1984), "Clinical Problems and the Concept of Disease", in Lennart Nordenfelt and B. Ingemar B. Lindahl.(eds,), Health, Disease, and Causal Explanations in Medicine. Dordrecht: D. Reidel.
15. Giere, Ronald N. (1988), Explaining Science: A Cognitive Approach. Chicago: University of Chicago Press.
16. _ (1999), Science without Laws, Chicago: University of Chicago Press.
17. Hahn, William C., and Robert A. Weinberg (2002a), "Modelling the Molecular Circuitry of Cancer", Nature Reviews Cancer 2: 331-334.
18. _ (2002b), "A Subway Map of Cancer Pathways", http://www.nature.com/nrc/journal/v2/n5/weinberg_poster/.
19. Hempel, Carl G. (1965), Aspects of Scientific Explanation. New York: The Free Press.
20. Hesslow, Germund (1993), "Do We Need a Concept of Disease?", Theoretical Medicine 14: 1-14.
21. Humber, James M., and Robert F. Almeder (eds.) (1997), What Is Disease? Totowa, NJ: Humana Press.
22. Hupp, Ted R., David P. Lane, and Kathryn L. Ball (2000), "Strategies for Manipulating the P53 Pathway in the Treatment of Human Cancer", Biochemical Journal 352; 1-17.
23. Karp, Peter (2001), "Pathway Databases: A Case Study in Computational Symbolic Theories", Science 293: 2040-2044.
24. Kitcher, Philip (1993), The Advancement of Science. Oxford: Oxford University Press.
25. Leaks, David B. (1992), Evaluating Explanations: A Content Theory. Hillsdale, NJ: Erlbaum.
26. Lodish, Harvey, Arnold Berk, S. Lawrence Zipursky, Paul Matsudaira, David Baltimore, and James Darnell (2000), Molecular Cell Biology, 4th ed. New York: W. H. Freeman.
27. Machamer, Peter, Lindley Darden, and Carl F. Craver (2000), "Thinking About Mechanisms", Philosophy of Science 67: 1-25.
28. Mandel, Siegfried (1969), Dictionary of Science. New York: Dell.
29. McLaughlin, Peter (2001), What Functions Explain. Cambridge: Cambridge University Press.
30. Messer, William S., Jr. (2002), "Mbc 3320 Dopamine", http://www.neurosci.pharm.utoledo.edu/MBC3320/dopamine.htm.
31. Moran, Laurence A., K. Gray Scirmgeour, H. Robert Horton, Raymond S. Ochs, and J. David Rawn (1994), Biochemistry. Englewood Cliffs, NJ: Prentice Hall.
32. NCI (National Cancer Institute) (2002), "Making the Connections for a Targeted Cancer Treatment Takes Time and Perseverance", http://plan.cancer.gov/infra/sod.htm
33. Reznek, Lawrie (1987), The Nature of Disease. London: Routledge & Kegan Paul.
34. Salmon, Wesley C. (1984), Scientific Explanation and the Causal Structure of the World. Princeton: Princeton University Press.
35. _ (1989), "Four Decades of Scientific Explanation", in Phillip Kitcher and Wesley C. Salmon (eds.), Scientific Explanation, Minnesota Studies in the History of Science, vol. 13. Minneapolis: University of Minnesota Press, 3-219.
36. Sapp, Shawn A. (2002), "Metamol Gallery", http://lamar.colostate.edu/~sasapp/metamol-gallery.html.
37. Schaffner, Kenneth F. (1993), Discovery and Explanation in Biology and Medicine. Chicago: University of Chicago Press.
38. Schank, Roger C. (1986), Explanation Patterns: Understanding Mechanically and Creatively. Hillsdale, NJ: Erlbaum.
39. Steffan, Joan S. et al. (2001), "Histone Deacetylase Hinhiborts Arrest Polyglutamine-Dependent Neurodegeneration in Drosophila ital", Nature 413: 739-743.
40. Thagard, Paul (1988), Computational Philosophy of Science. Cambridge, MA: MIT Press/Bradford Books.
41. _ (1992), Conceptual Revolutions. Princeton: Princeton University Press.
42. _ (1999), How Scientists Explain Disease. Princeton: Princeton University Press.
43. _ (2002a), "Curing Cancer? Patrick Lee's Path to the Reovirus Treatment", International Studies in the Philosophy of Science 16: 179-193.
44. _ (2002b), "How Molecules Matter to Mental Computation", Philosophy of Science 69: 429-446.
45. Therapeutics Initiative (2002), "Angiotensin II Receptor Blockers", http://www.ti.ubc.ca/pages/letter28.htm.
46. Woolfolk, Robert L. (1999), "Malfunction and Mental Illness", Monist 82: 658-670.